COMMUNIQUÉS West-GlobeNewswire

Antares Pharma Provides XYOSTED™ Regulatory Update

05/04/2018 - 13:00

Complete Response Resubmission Accepted – PDUFA Date September 29, 2018 EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that the U.S. Food and Drug [...]

Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

05/04/2018 - 13:00

REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences [...]

Stemline Therapeutics Announces Start of Rolling BLA Submission for SL-401

05/04/2018 - 13:00

NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that it has initiated its [...]

Avivagen Announces an Amendment to its Stock Option Plan

05/04/2018 - 12:30

OTTAWA, April 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]

TRU NIAGEN® to be featured at the American Academy of Anti-Aging Medicine Spring Congress

05/04/2018 - 12:30

Keynote Speaker, Dr. Rudolph E. Tanzi, will sign copies of his new book, “The Healing Self,” at the TRU NIAGEN booth IRVINE, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, [...]

Aino Health AB (publ): Aino Health launches work ability and health management service desk for managers

05/04/2018 - 12:04

Aino Health is launching a new service that will support managers as an effective first point of contact in daily activities regarding work ability and health management. Aino will offer the service as a multichannel [...]

Innovate Biopharmaceuticals, Inc. to Present at the H.C. Wainwright Annual Global Life Sciences Conference on April 9, 2018

05/04/2018 - 12:03

RALEIGH, N.C., April 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, [...]

PotNetwork Holdings, Inc. Moves Forward on OTCQB Uplist Process

05/04/2018 - 12:00

Company Contemplates Name Change to more closely align its corporate identity with becoming a dominant player in the rapidly-growing CBD industry FT LAUDERDALE, Fla., April 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE [...]

RadNet Becomes the Largest Outpatient Imaging Operator in the Greater Fresno, California Area with the Acquisition of Five Imaging Centers

05/04/2018 - 12:00

LOS ANGELES, April 05, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it acquired [...]

Summit Therapeutics plc : Holding(s) in Company

05/04/2018 - 11:46

TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]

AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease

05/04/2018 - 10:01

Tau small molecules (Tau Morphomers) demonstrate target-specific reduction of pathological Tau as well as cognitive and functional improvement Significant reduction of microglia activation enhances the benefits on Tau [...]

Elsalys Biotech : LEUKOTAC takes next step in paediatric acute steroid-resistant GvHD

05/04/2018 - 09:00

LEUKOTAC® takes next step in paediatric acute steroid-resistant GvHD ELSALYS BIOTECH plans to submit to the European Medicines Agency before summer 2018 a Paediatric Investigation Plan (PIP) proposing to conduct a [...]

Elsalys Biotech : LEUKOTAC, les prochaines étapes dans la GvHD aigüe et cortico-résistante en pédiatrie

05/04/2018 - 09:00

LEUKOTAC ® , les prochaines étapes dans la GvHD aigüe et cortico-résistante en pédiatrie ELSALYS BIOTECH prévoit de déposer avant l'été 2018 un plan d'investigation pédiatrique (PIP) auprès de l'Agence Européenne du [...]

Shire plc : Rule 2.9 Announcement

05/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 April 2018 Shire [...]

OSE Immunotherapeutics to Host Conference Call on April 5, 2018 to Discuss Boehringer Ingelheim Global Immuno-Oncology Partnership

05/04/2018 - 07:30

NANTES, France, April 05, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announced that it will host an audio/web conference to discuss its global immuno-oncology partnership [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

05/04/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 5 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

05/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 5 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Santhera Announces Successful Completion of First Clinical Trial with Omigapil in Patients with Congenital Muscular Dystrophy

05/04/2018 - 07:01

Pratteln, Switzerland, April 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports the successful completion of the first clinical trial with omigapil in patients with two forms of congenital muscular dystrophy (CMD) [...]

Biocartis Group NV: Biocartis announces publication of its 2017 annual report

05/04/2018 - 07:01

PRESS RELEASE : REGULATED INFORMATION 5 April 2018, 07:00 CEST Biocartis announces publication of its 2017 annual report Mechelen, Belgium, 5 April 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]